A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The two COVID-19 vaccines approved in Canada were created by using ground-breaking genetic technology that for years held huge promise, but always ran into roadblocks — until now. It’s called ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

A positive effect that COVID-19 vaccines would have on the human body has been discovered. The technology used in these vaccines could also lead scientists to a cure for the human immunodeficiency ...

Scientists dropped everything to focus on a COVID-19 vaccine. Its success will change the future of medicine (Frauke Bönsch) In the early days of the COVID-19 pandemic, when the novel coronavirus was ...

Power Play: Quach on NACI's J&J advice Dr. Caroline Quach discusses NACI's advice for the Johnson & Johnson vaccine, which seems to contradict what's coming from Health Canada.

Covid vaccines turned mRNA treatments from a long-simmering research topic into a dinner table conversation. We remember the shot all too well. But these have a universal problem: Needles. Rather than ...